Skip to main content
Log In
More
Log in via Institution
Log in via OpenAthens
Log in using your username and password
For personal accounts OR managers of institutional accounts
Username
*
Password
*
Forgot your log in details?
Register a new account?
Forgot
your user name or password?
Basket
Search
More
Search for this keyword
Advanced search
Latest content
Browse by collection
Archive
Authors
About
Search for this keyword
Advanced search
Close
More
Main menu
Latest content
Browse by collection
Archive
Authors
About
Log in
More
Log in via Institution
Log in via OpenAthens
Log in using your username and password
For personal accounts OR managers of institutional accounts
Username
*
Password
*
Forgot your log in details?
Register a new account?
Forgot
your user name or password?
BMJ Journals
You are here
Home
Archive
Volume 8, Issue Suppl 3
312 Female sex independently predicts adjuvant immunotherapeutic benefit from CTLA4 immune checkpoint inhibition
Email alerts
Article metrics
Article menu
Article
Text
Article
info
Citation
Tools
Share
Rapid Responses
Article
metrics
Alerts
PDF
XML
Regular and young investigator award abstracts
Clinical trials completed
312 Female sex independently predicts adjuvant immunotherapeutic benefit from CTLA4 immune checkpoint inhibition
Online download statistics by month:
Online download statistics by month: November 2020 to May 2022
Abstract
Full
Pdf
Nov 2020
126
0
14
Dec 2020
79
0
6
Jan 2021
18
0
4
Feb 2021
34
0
7
Mar 2021
52
0
8
Apr 2021
42
0
2
May 2021
12
0
4
Jun 2021
0
0
6
Jul 2021
0
0
6
Aug 2021
0
0
5
Sep 2021
0
0
11
Oct 2021
54
0
21
Nov 2021
23
0
17
Dec 2021
28
0
2
Jan 2022
12
0
3
Feb 2022
28
0
0
Mar 2022
78
0
6
Apr 2022
54
0
1
May 2022
28
0
6
Total
668
0
129
Read the full text or download the PDF:
Subscribe
Log in
Log in via Institution
Log in via OpenAthens
Log in using your username and password
For personal accounts OR managers of institutional accounts
Username
*
Password
*
Forgot your log in details?
Register a new account?
Forgot
your user name or password?
PDF